Alafair Biosciences
Austin, US · Founded 2011 · Delaware corporation · 3 known investors
Alafair Biosciences develops naturally-derived hydrogel products for soft-tissue protection during surgery, using a hyaluronic acid and alginate technology to create a protective gliding surface that prevents postoperative tissue tethering and scarring. Its products, sold as a hydrogel sheet and a flowable syringe-deliverable gel, are used by surgeons to protect tendons and peripheral nerves during soft-tissue procedures.
BiotechMedical DevicesNew Materials
Founders & leadership
RW
Robert WillsDirector
DP
Daniel PetersonExecutive Officer, Director
CL
Christophe LavigneDirector
JB
John B. Henneman, IIIDirector
JP
James P. FellerDirector
JJ
John JoyoprayitnoExecutive Officer
JD
Jerry DeVriesDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$2.3MraisedOct 2018 · 15 investors · BiotechnologyRule 506(b)
▶$2.3MraisedOct 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel PetersonDirector
- Jerry DeVriesDirector
- Mark BenedykDirector
- James Patrick FellerDirector
- Kyle A. CoxDirector
- John B. HennemanDirector
- John JoyoprayitnoExecutive Officer
- R. Gregory BrophyExecutive Officer
- Offering amount
- $6.8M
- Amount sold
- $2.3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$965KraisedJul 2017 · 9 investors · BiotechnologyRule 506(b)
▶$965KraisedJul 2017 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel PetersonDirector
- John B. HennemanDirector
- R. Gregory BrophyExecutive Officer
- John JoyoprayitnoExecutive Officer
- James Patrick FellerDirector
- Jerry DeVriesDirector
- Kyle A. CoxDirector
- Jim GamettDirector
- Offering amount
- $2M
- Amount sold
- $965K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$984KraisedOct 2015 · 11 investors · BiotechnologyRule 506(b)
▶$984KraisedOct 2015 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert WillsDirector
- Daniel PetersonExecutive Officer, Director
- Jerry DeVriesDirector
- Christophe LavigneDirector
- John B. Henneman, IIIDirector
- James P. FellerDirector
- John JoyoprayitnoExecutive Officer
- Offering amount
- $2M
- Amount sold
- $984K
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.